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Introduction
============

Lyme disease (LD) is the most prevalent vector-borne infection in the northern hemisphere, and its incidence continues to increase[@B0]. This debilitating illness is caused by spirocheteal pathogens of the Lyme borreliosis (LB) complex (commonly referred to as *Borrelia burgdorferi* sensu lato, or s.l.), which historically comprises the predominant North American pathogen, *B. burgdorferi* sensu stricto (s.s), in addition to *B. afzelii* and *B. garinii,* which are widespread throughout Europe and Asia, and are species of emerging clinical relevance[@B1][@B2]. These bacteria are transmitted to humans through the bite of infected *Ixodes* ticks[@B1]*.* Although the main North American vectors are *I. scapularis* and *I. pacificus*, multiple species within this genus have been found to harbor and transmit the bacterium[@B3]. In humans, *B. burgdorferi* can cause multisystem symptoms affecting the skin, joints, heart, nervous system, endocrine glands, gastrointestinal tract, and internal organs[@B4][@B5][@B6][@B7][@B8][@B9]. The Center for Disease Control and Prevention currently estimates over 300,000 new human cases annually in the United States[@B10][@B11]. While prognosis is often favorable when the illness is diagnosed and treated in the early stages, studies have suggested that anywhere between 10% and 60% of patients who received the recommended antibiotic regimen continued to experience symptoms after therapy cessation, in a phenomenon termed Post Treatment Lyme Disease Syndrome (PTLDS)[@B12][@B13][@B14]. Moreover, delays in clinical intervention can arise as a result of lack of awareness of a tick bite, non-specific presentation of the initial illness, and the low sensitivity of traditional serology-based diagnostics when used at the onset of infection. Failure to treat swiftly and appropriately enables symptom progression that can manifest in increasingly debilitating complications[@B15][@B16]. Lyme disease prevention is therefore a cornerstone of risk management. Strategies to combat this growing threat include robust surveillance measures to indicate the pathogen prevalence in ticks, and identify geographic regions of concern.

This article demonstrates the utility of nested polymerase chain reaction (nPCR) as a molecular screening tool by which to identify infected ticks. To increase specificity, two *Borrelia* genes are used for parallel amplification. *Flagellin B (FlaB)* encodes a major filament protein of the flagellum[@B17], and the gene is located on the single linear chromosome, while the lipoprotein product of *Outer surface protein A* (*OspA*) mediates tick midgut colonization, and is plasmid-encoded[@B18][@B19]. The workflow consists of tick collection, DNA extraction, and then an initial round of PCR to detect *Borrelia*-specific loci. Subsequent PCR uses the product of the first reaction as a new template to generate smaller, internal amplification fragments. A tick is considered positive for *Borrelia burgdorferi* when inner amplicons from both *Borrelia* genes can be detected by agarose gel electrophoresis.

Both the nPCR technique, and the *FlaB* and *OspA* gene targets, have been widely used for ecological surveillance and clinical detection of the Lyme spirochete since the early 1990s[@B20][@B21][@B22][@B23][@B24]. Prior to the development of molecular protocols, ticks were assessed by subjecting gut contents to anti-*Borrelia* immunofluorescence (IF) staining, microbial culture, or a combination thereof[@B25]. These approaches suffer from inherent limitations, including the slow growth and fastidious nature of *Borrelia*[@B26], antibody performance issues, and the requirement of live ticks for IF processing[@B20]. PCR was subsequently adopted to provide fast, sensitive, and specific identification of infected vectors. It offered marked improvements over the traditional methodology, including culture-independent direct application to diverse specimen types, such as dead and archived ticks that would otherwise be unsuitable for testing[@B20][@B21]. Nested experimental designs further improve upon the specificity and sensitivity of classical PCR by employing two distinct sets of gene-specific primers in two consecutive rounds of amplification[@B24][@B27].

Experimental success is critically dependent on strategic gene selection and amplicon design. To accurately estimate the presence of *Borrelia burgdorferi*, primers should detect the relevant pathogens without cross-reacting with relapsing fever spirochetes also in the *Borrelia* genus. In the case of *FlaB*, this specificity is achieved by targeting a variable internal region of the gene, rather than the relatively conserved flanking sequences that are shared by diverse bacteria (**Figure 1**)[@B23][@B28][@B29].

**Figure 1: The concept of nPCR, as illustrated using*****Borrelia FlaB*****gene as a target.**The 5\' and 3\' termini of the gene are common to organisms beyond *Borrelia burgdorferi* s.l., rendering these regions unsuitable for the specific assessment of Lyme-causing pathogens. Using the less-conserved interior sequences as primer targets, two rounds of PCR are executed to detect a final, internal amplicon. [Please click here to view a larger version of this figure.](//cloudflare.jove.com/files/ftp_upload/56471/56471fig1large.jpg)

In a test of their discriminatory capacity, interior *FlaB* primers were evaluated with over 80 different *Borrelia* isolates, and found to identify only those associated with Lyme disease[@B23]. The lower detection limit of nPCR has been documented at between six[@B23] and ten[@B30] bacteria from pure culture, although the sensitivity can be further improved by Southern blotting the amplicon, and hybridizing a radiolabelled or chemiluminescent probe. Coupling the techniques reduces the detection threshold to a single spirochete[@B30]. By direct comparison, conventional, unprobed single-round PCR was found to report the presence of a minimum of 10[@B3] spirochetes[@B30]. It should be noted, however, that assay sensitivity will be lower when working with complex environmental and clinical samples, due to the overwhelming presence of unrelated DNA and potential inhibitory substances. These challenges can be largely circumvented by the use of nPCR.

Despite advances in molecular technologies in the past decades, nPCR remains a staple technique in modern surveillance efforts. If care is taken in the design and execution of this protocol, it is a powerful, adaptable, and relatively straightforward approach to capture the presence of pathogens in tick vectors.

Protocol
========

1. DNA Isolation from Ticks
---------------------------

1.  Acquire ticks via field collection, or passive surveillance from veterinarians and members of the public. Ticks should be killed by freezing, placed in a sealed bag, and mailed at room temperature. Using a submission form, gather information on the date and geographic location of the encounter, tick attachment status, host species, and recent travel history of the host.Since nested PCR is inherently vulnerable to contamination, ensure that the laboratory workspace is set up to minimize cross-exposure of samples. This involves executing different elements of the protocol in separate, dedicated spaces well isolated from each other that are thoroughly cleaned and sterilized, and ensuring that all instruments are free of contaminants.Upon receiving the specimen, photograph the tick and determine species, developmental stage, sex, and engorgement status by comparison to an identification key[@B31] .Under aseptic conditions, bisect the tick using a sterile razor blade or scalpel, and place the two tick fragments into separate microcentrifuge tubes.

2.  To extract total DNA, use any isolation procedure that yields PCR-compatible template; this protocol demonstrates a simple chelation-based approach. Begin by adding an appropriate volume (often between 50 - 200 µL) of a lytic chelation reagent to the tick fragment. The specific amount will depend on the specimen size and engorgement status; guidelines should be provided by the manufacturer. Homogenize using a microtube pestle.Incubate samples in a water bath at 60 °C for 45 min, and vortex briefly.Centrifuge samples for 4 min at 16,276 x g (13,300 rpm) in a desktop microcentrifuge.Transfer supernatant to a fresh, labeled microtube containing 50 µL isopropanol, mix by inversion, and re-centrifuge as in (1.2.3).Decant the supernatant, and rinse the DNA pellet with 50 µL of 70% ethanol.Remove excess ethanol with a pipette, and allow the pellet to air-dry for 15 min at room temperature.To resuspend DNA, add 50 µL of 1 mM Tris pH 7.0, and incubate samples in a water bath for 1 h at 60 °C. The DNA can now be stored at -20 °C for future molecular analysis.

2. Nested PCR Detection of *Borrelia OspA* and *FlaB*.
------------------------------------------------------

NOTE: An overview of general PCR principles and practices is provided by Lorenz, 2012[@B32].

1.  Synthesize or obtain *Borrelia* gene-specific outer and inner oligonucleotide primers. See **Table 1** for primer sets, their respective amplicon sizes, and melting temperatures.

  ----------------- ----------------- ----------------------- ------------------- ---------------------------
  **Primer Name**   **Gene Target**   **Sequence (5'-3')**    **Amplicon Size**   **Annealing Temperature**
  FlaB Out Fw       FlaB              gcatcactttcagggtctca    503 bp              55°C
  FlaB Out Rv       FlaB              tggggaacttgattagcctg                        
  FlaB In Fw        FlaB              ctttaagagttcatgttggag   447 bp              58°C
  FlaB In Rv        FlaB              tcattgccattgcagattgt                        
  OspA Out Fw       OspA              cttgaagttttcaaagaagat   487 bp              55°C
  OspA Out Rv       OspA              caactgctgacccctctaat                        
  OspA In Fw        OspA              acaagagcagacggaaccag    350 bp              58°C
  OspA In Rv        OspA              ttggtgccatttgagtcgta                        
  ----------------- ----------------- ----------------------- ------------------- ---------------------------

**Table 1: Inner and outer primers for nPCR of Borrelia burgdorferiFlaB and OspA.** In practice, the *FlaB* primers detect *B. burgdorferi* s.s. and other closely related *Borrelia* genospecies, while *OspA* primers capture only *B. burgdorferi* s.s. Amplification from both loci would indicate *B. burgdorferi.* s.s.

1.  Pre-sterilize a PCR cabinet with UV light and 70% ethanol. NOTE: To minimize potential sample contamination, this workspace should be distinct from the location of tick dissection, DNA extraction, and gel electrophoresis. For the initial PCR run, use the outer primers in conjunction with the template DNA recovered in step 1.0 above, and set up the reaction mixture as described in **Table 2**. In parallel, perform positive control runs consisting of verified *Borrelia* DNA, and negative control runs including no-template reactions to detect reagent and aerosol contamination. Add DNA at the end to minimize potential contamination of reagents. Ensure each tube is closed at all times when reagents are not being added and close tubes immediately after DNA addition and before other tubes are opened.Program a thermal cycler as follows: 95 °C for 5 min; 40 cycles of 95 °C for 15 s, annealing temperature for 30 s, 72 °C for 45 s; 72 °C for 5 min; and hold at 4 °C.

2.  Perform the second round of PCR similar to the first reaction, except use inner primers with 2 µL of the first PCR product (produced in 2.2.2). NOTE: Reaction volumes are again provided in **Table 2**. Care must be taken to avoid cross-contamination of amplicons by ensuring that template DNA is added last and that only tubes corresponding to one sample are open at a time.   **ComponentPCR \# 1 VolumesPCR \# 2 Volumes**Taq Polymerase Master Mix 2X12.5 µL12.5 µLNuclease-free Water8.5 µL8.5 µL10 µM Forward and Reverse primers1.0 µL Outer Primers1.0 µL Inner PrimersDNA Template2.0 µL, from sample extraction (1.2.7)2.0 µL, from round 1 of PCR (2.2.2) **Table 2: PCR reaction mixtures for first and second amplifications.**   Program the thermal cycler as before, but adjust the annealing temperature to accommodate the inner primers (refer to Table 1).

3. Agarose Gel Electrophoresis and Imaging
------------------------------------------

NOTE: For basic instructions on separating DNA by electrophoresis, see Lee *et al*., 2012[@B33].

1.  Prepare a 1.2% agarose gel using 20X SB buffer (0.2 M NaOH, 0.8 M Boric Acid pH 8), diluted to 1X, and add approximately 5 µL of a DNA stain, before pouring, if pre-staining of the gel is desired.

2.  Load 10 µL of the product from the second (inner) PCR reaction from each experimental and control sample, alongside a 100 bp ladder (5 µL). Electrophorese for 1 h at 107 V (5V/cm).

3.  View and document the gel using a transilluminator and associated camera and software.

Representative Results
======================

nPCR is an elegant approach to increase the specificity and sensitivity of pathogen detection, particularly when complex environmental samples are under investigation. As depicted in [Figure 1](#F1){ref-type="fig"}, two rounds of PCR targeting a strategic region of the *Borrelia FlaB* locus (and *OspA*, not pictured) can report the presence of the *Borrelia burgdorferi* bacteria through the generation of short inner amplicons. When resolved by gel electrophoresis, the *FlaB* and *OspA* reaction products from each tick can be visually scored and compared against controls. In [Figure 2](#F2){ref-type="fig"}, unique specimen identifiers are provided along the top of each gel, and no-template and aerosol controls are represented at the far left and right, respectively, adjacent to the ladders.

Robust amplicon bands are clearly visible in select experimental samples, and they are easily distinguished from surplus primers and residual DNA ([Figure 2](#F2){ref-type="fig"}). Based on the experimental design principles set forth, a tick is considered positive for *Borrelia* when parallel negative controls demonstrate no amplification, and inner amplicons are produced from both *FlaB* and *OspA* primers. In this case, specimens T907, T604, and T606 met surveillance criteria for the Lyme pathogen ([Figure 2](#F2){ref-type="fig"}). By contrast, T923 was only positive for *OspA*, an outcome for which there are multiple possible explanations: A) The tick of origin was negative for *Borrelia*, but the outer or inner *OspA* PCR preparation was spuriously contaminated with template DNA (note that systemic contamination of reagents was ruled out via negative controls), B) the tick carried Lyme *Borrelia*, but low template amounts or experimental error prevented amplification of *FlaB*, or C) an organism was present that contained the conserved *OspA* sequence, but lacked *Flagellin* or had insufficient identity in the targeted region of *FlaB* to anneal to the primers. Indeed, *OspA* sequence similarities have been noted in a variety of organisms, including plants and animals[@B27]. The converse situation, amplification of the more conserved *Flagellin* gene, but not the *OspA* gene, could indicate a related *Borrelia *species. In practice, this protocol yields more *OspA* single-positive results than do the *FlaB* primers, suggesting that scenario \'A\' is the least likely explanation. Without further experimental analysis of the contentious specimen, however, it is not possible to determine the source of the single-positive result. Increasing the number of technical replicates performed on equivocal samples may help to reconcile their true status, since any contaminants that were spuriously introduced to previous reactions would not be present in the archived DNA. However, if subsequent reactions with these primers fail to provide conclusive results, other *Borrelia* loci could be investigated by PCR. Amplicons generated from these reactions could also be sequenced and compared among isolates to help assign identity, and estimate the degree of strain divergence. Sapi and colleagues provide an example of this workflow using human clinical samples[@B34].

All factors considered, the outlined protocol and interpretation criteria have been estimated to yield false positive and false negative rates of 0.17% and 0.0063%, respectively.

[Figure 2](#F2){ref-type="fig"}**: Detection of*****Borrelia burgdorferi*****in individual ticks by nPCR of*****FlaB*****and*****OspA.***Codes assigned to each tick are represented across the top of the gels, and identities align vertically to report the detection of *OspA*and*FlaB*in each specimen. Lanes entitled B at the left of the image represent no-template controls, while A (right hand lanes) are aerosol controls to capture contamination of the laboratory environment. [Please click here to view a larger version of this figure.](https://cloudflare.jove.com/files/ftp_upload/56471/56471fig2large.jpg)

Discussion
==========

Over decades of use, PCR-based techniques have consistently proven their value in the detection of *Borrelia* from arthropod and mammalian specimens, whether *Borrelia* come from environmental or clinical origins. PCR offers many improvements over pre-existing approaches to surveillance. Notably, it is not reliant on the development and performance of antibody reagents, and instead can be easily adapted to detect new targets of interest simply by modifying primer sequences. PCR also accommodates the evaluation of multiple loci in parallel, either independently or via a multiplex reaction. It can be applied to diverse specimen inputs, including fresh and archived ticks[@B21], animal or human bodily fluids, and resected tissue[@B24]. PCR also yields amplicons that can be further processed, for example by restriction enzyme digestion, probe hybridization, or sequencing, to provide increased insight into microbial identity[@B20].

As a clinical tool, PCR is conceptually preferable to the standard serological diagnostics, as it provides a direct indication of bacterial presence, rather than relying on host immune response as a secondary measure of infection. However, Lyme borreliosis is associated with a relatively modest microbial burden (\<50 organisms/mL of urine or plasma) and transient spirochetemia, which can give rise to false negative results[@B24]. The sensitivity of this technique in the clinic varies considerably depending on the tissue type, stage of infection, and sample condition, falling between 12.5% and 62% in existing studies of blood, cerebrospinal fluid, and biopsied tissue[@B35]. Molecular sensitivity limitations are not a concern if PCR is undertaken subsequent to bacterial culture, however recovery of viable spirochetes from clinical specimens has proven similarly challenging. Only recently have protocols been optimized for higher yield[@B34]. Meanwhile, the gut of an infected adult tick can harbor on average anywhere from 2,000 to over 50,000 *Borrelia*[@B36][@B37][@B38], which is solidly within the detection range of nPCR. Thus, the protocol is well suited to tick surveillance efforts.

Despite its many advantages, nPCR does pose certain challenges, and the capacity of this technique to accurately report tick infection therefore depends on strategic selection of genes and amplicons, meticulous experimental workflows that recover quality DNA from specimens while minimizing cross-exposure of samples, and the use of appropriate controls that can report contaminants in the laboratory environment and reagents. Prior to any experimentation, the scope and intentions of the investigation should be clearly defined so that appropriate genetic loci, and regions therein, can be selected. If the objective is to provide an unbiased screen for the Lyme-causing *Borrelia burgdorferi* s.l. complex, primers should be created to detect all of the associated strains with similar affinity and amplification efficiency, without capturing unrelated organisms[@B24]. New primers can be designed and assessed *in silico* using software tools such as Primer-BLAST[@B39], although they should also be validated experimentally against standard reference isolates before being applied to uncharacterized samples. The goal of the DNA extraction procedure is to recover intact microbial template from a mixed environmental sample (tick homogenate). An optional step before proceeding with PCR is to evaluate the integrity of the extracted DNA. Additionally, parallel reactions could be set up to target a housekeeping gene in the tick. The latter method can also indicate the presence of inhibitors in the reaction mixture, providing increased confidence that negative *Borrelia* reactions are due to the absence of the organism, and not to the presence of an inhibitory contaminant.

The increased sensitivity of the nested PCR approach comes at the expense of potential contamination that generates false-positive results. Exogenous template could be introduced to a sample during tick dissection and DNA recovery, or in the process of setting up the outer and inner amplification reactions. It is therefore especially important to follow best practice protocols for PCR to avoid template or amplicon cross-contamination. These include the use of separate work stations with independent airflows, containment in PCR and biological safety cabinets where appropriate, thorough chemical and physical cleaning and sterilization of surfaces and reagents, and cautious handling of DNA[@B40]. No-template controls are also vital in identifying contamination of stock reagents. A particular vulnerability of nPCR is the amplicon handling that occurs when transferring the products of the first reaction into the second PCR vessel. Since the target DNA has already undergone exponential enrichment in positive samples, this step is especially prone to cross-contamination, and a single-tube nPCR protocol has been developed to circumvent this limitation. In this approach, both sets of primers for a given gene are added together to a reaction tube that remains sealed for both rounds of PCR[@B30]. The outer and inner primer pairs must be thermodynamically distinct, such that the outer couple amplifies template at a high annealing temperature that is prohibitive for the inner primers. In the second round, the annealing temperature is lowered to accommodate the internal pair. Not only does this bypass a potentially confounding step, it also permits the use of additional anti-contamination measures[@B30][@B41]. However, this modification may sacrifice some assay sensitivity. Regardless of the approach, increasing the number of technical replicates performed independently on a sample will help to identify spurious contamination.

Molecular techniques have continued to evolve since the introduction of nPCR, and these newer approaches offer select advantages over the original designs, albeit at increased financial expense. As the name suggests, quantitative PCR (qPCR or real time (RT)-PCR) allows for the enumeration of pathogens in a sample, while conventional techniques are qualitative in nature[@B42]. The sensitivity of qPCR is reportedly similar to that of nPCR[@B37], although it can fluctuate depending on primer characteristics[@B27]. A variation of qPCR that uses molecular beacons (MB) in place of conventional TaqMan probes has also shown promise in the detection of *Borrelia* in clinical specimens[@B43][@B44][@B45]. Due to their unique secondary structure, molecular beacons reportedly produce lower background fluorescence and higher legitimate signals, thereby providing superior sensitivity[@B46]. Pre-clinical evaluations suggest a potential detection threshold of between one and ten spirochetes[@B43][@B44]. Moreover, the technique has been successfully applied in multiplex reactions to simultaneously detect a mammalian host gene[@B43] and other tick-borne pathogens[@B44], which is not as readily achievable with nPCR. Other design modifications include droplet digital PCR (ddPCR) technology, which can quantify DNA without the use of a standard curve[@B38][@B47]. The lower detection limit of this technique for *Borrelia* is likewise around ten spirochetes/sample[@B38]. Compared to nPCR, these approaches also have the advantage of reduced potential for contamination, as they only require a single amplification protocol.

If the objective of surveillance is instead to profile the varied bacterial contents of a tick, 16S rRNA metagenomic screening is an attractive option[@B48]. Although this approach is costlier, requires specialized DNA sequencers not found in all molecular biology laboratories, and necessitates more sophisticated bioinformatics-based interpretation, it can capture a broad spectrum of microbes to more accurately represent the pathogen load of the vector.

While qPCR and its derivatives are methods of choice for quantitative applications, and metagenomics screens provide broad inventories of the tick microbiome, targeted surveillance efforts are often concerned with binary reporting of the presence or absence of one or a few pathogens in a vector. Under such circumstances, these newer, more elaborate approaches may introduce unnecessary complexity and financial burden into the process. For these reasons, nPCR has withstood the test of time as a pivotal technique in tick testing.
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